What is the primary peritoneal cancer?
Primary peritoneal cancer is a rare form of cancer originating in epithelial cells lining peritoneum, a layer of tissue inside the abdomen designed to ensure the protection and support of the abdominal organs. This cancer is treatable and the prognosis varies depending on the cancer stage when identified. Unfortunately, primary peritoneal cancer is often identified at a late stage as a result of vague symptoms; Patients may not immediately seek treatment and it may take time to trace the cause of symptoms.
This cancer is most often developed around the pelvis and is closely associated with ovarian cancer. Ovarian cancer often spreads to peritoneum, and primary peritoneal cancer can also spread to the ovaries because they are the same types of epithelial cells. Due to the combination of ovarian cancer, it is important to check patients with peritoneal cancer for ovarian cancer, find out where cancer comes and check signs of metastases.
Men rarely develop this cancer. U žEN are unclear, but the incidence is much higher in women with mutations in the BRCA gene, a gene associated with breast and ovarian cancer. Women with a variant or mutated BRCA genes should make sure that they are regularly checked so that breast and ovarian cancer will capture such cancer soon if they evolve. In some cases, prophylactic treatment can also be considered if the patient is particularly high risk.
symptoms of primary peritoneal cancer include weight gain, swelling in the abdomen, nausea, loss of appetite, lethargy, stomach pain and change in toilet habits such as free stool or coloring in urine. Screening for this cancer may include physical examination, medical imaging studies and biopsy. During the diagnosis process, cancer will also be presented and determined how aggressive it is and how far it has spread.
Available treatment for primary peritoneal carcinomaIt includes surgery for consumer tumors, radiation therapy for killing cancer cells and chemotherapy by means of drugs to target and destroy cancer cells. The recommendations of treatment will vary depending on the cancer stage, the age of the patient and the interviews between the patient and the oncologist. When checking the treatment options, it may be useful to ask about forecasts with different treatments and explore the possibilities of clinical evaluation. In addition to providing valuable data for diagnosis and treatment of cancer, clinical studies can provide access to new treatments except that they benefit future generations of patients.